Fortress Biotech, Inc. (NASDAQ:FBIOP) Sees Significant Increase in Short Interest

Fortress Biotech, Inc. (NASDAQ:FBIOP) was the recipient of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 1,800 shares, an increase of 1,700.0% from the October 31st total of 100 shares. Based on an average daily volume of 19,600 shares, the short-interest ratio is presently 0.1 days.

Fortress Biotech Stock Down 0.6 %

Shares of Fortress Biotech stock traded down $0.03 during trading on Wednesday, hitting $5.19. The company’s stock had a trading volume of 9,579 shares, compared to its average volume of 17,473. The company has a fifty day simple moving average of $5.36 and a two-hundred day simple moving average of $9.05. Fortress Biotech has a 52 week low of $4.86 and a 52 week high of $18.00.

Fortress Biotech Company Profile

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.